Skip to main content

Table 5 Patient-related recurrent costs (US$)

From: Costs of a successful public-private partnership for TB control in an urban setting in Nepal

   Costs
Category of cost Number of patients reporting non-zero cost Total reported Min value Max value Per patient per 8 months  
      Median Mean
Expenses with traditional healers 11 305 0 141 0.0 7.0
Diagnosis stage (excluding travel)       
   Consultation charges 48 196 0 16 1.5 4.5
   Investigations 50 830 0.1 119 7.5 19.0
Sub-Total Diagnosis   1,026 0.2 132 10 23.4
Treatment (excluding medicines and travel)       
   Consultation charges 14 66 0 15 0.0 1.5
   Investigations 31 57 0 12 0.2 1.3
Sub-Total Treatment   123 0 27 0.3 2.8
Patients' travel and opportunity costs       
   Travel expenses 11 184 0 37 0.0 4.2
   Opportunity costs of days lost due to TB 18 5,152 0 1,755 0.0 117.8
   Opportunity costs of travel time 50 842 1.8 202 8.8 19.3
Sub-Total Patients' Travel   6,179 2.4 1,780 3.8 141.2
Costs of escorts (travel time lost + cost of travel)       
   Travel expenses 6 73 0 40 0.0 1.7
   Opportunity costs of travel time 33 146 0 44 0.9 3.3
Sub-Total Costs of Escorts   219 0 84 0.9 5.0
Other (miscellaneous) expenditures 5 100 0 36 0.0 2.3
TOTAL PATIENTS' COSTS   7,952    35.90 181.80
  1. A breakdown of patient-related recurrent costs across main categories is presented. Frequency of costs from the total n = 50 is reported and total reported costs are shown versus median per patient's treatment course.
  2. Note 1: The numbers of patients who reported costs are based on the total sample of 50.
  3. Note 2: Minimum and maximum values and medians were derived for each type of costs separately and sub-totals in these columns are NOT the sums of their respective constituent costs.
  4. Note 3: An increment from 7 months (median of patients' month at which costing data was collected) to 8 months (standard duration of treatment) was used to estimate mean values per patient per 8 months